Suppr超能文献

VE-他汀/Egfl7小干扰RNA在体外抑制恶性胶质瘤血管生成。

VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.

作者信息

Huang Chunhai, Yuan Xianrui, Li Zhao, Tian Zhi, Zhan Xianquan, Zhang Jingjing, Li Xuejun

机构信息

Department of Neurosurgery, First Affiliated Hospital of Jishou University Jishou 416000, Hunan.

Department of Neurosurgery, Xiangya Hospital, Central South University Changsha 410008, Hunan, China ; The Institute of Skull Base Surgery and Neurooncology at Hunan Changsha 410008, Hunan, China.

出版信息

Int J Clin Exp Pathol. 2014 Feb 15;7(3):1077-84. eCollection 2014.

Abstract

This study investigated the role of VE-statin/Egfl7 and its mechanism in angiogenesis in malignant glioma. Transwell culture plates were used to establish an U251-HUVEC co-culture system, which was used to mimic the interaction between malignant glioma and endothelial cells. Lentiviral vectors expressing VE-statin/Egfl7 siRNA were constructed, and U251 cells and HUVECs were transfected to inhibit VE-statin/Egfl7 expression. The proliferation, adherence, migration, and lumen formation of endothelial cells were assayed to investigate the influence of VE-statin/Egfl7 on angiogenesis in malignant glioma in vitro. Data showed that HUVEC growth was temporarily slowed after silencing the VE-statin/Egfl7 gene but rapidly returned to normal. Although endothelial cell migration was not influenced, cell adherence was markedly inhibited. Furthermore, the endothelial cells failed to generate a capillary-like lumen after VE-statin/Egfl7 gene silencing. Therefore, it can be concluded that VE-statin/Egfl7 may regulate the adherence of endothelial cells, thus playing an important role in endothelium-induced lumen formation during angiogenesis in malignant glioma.

摘要

本研究探讨了VE-他汀/Egfl7在恶性胶质瘤血管生成中的作用及其机制。采用Transwell培养板建立U251-HUVEC共培养体系,以模拟恶性胶质瘤与内皮细胞之间的相互作用。构建表达VE-他汀/Egfl7 siRNA的慢病毒载体,并转染U251细胞和HUVECs以抑制VE-他汀/Egfl7的表达。检测内皮细胞的增殖、黏附、迁移及管腔形成,以研究VE-他汀/Egfl7对恶性胶质瘤血管生成的体外影响。数据显示,沉默VE-他汀/Egfl7基因后,HUVEC生长暂时减慢,但迅速恢复正常。虽然内皮细胞迁移未受影响,但细胞黏附明显受到抑制。此外,VE-他汀/Egfl7基因沉默后,内皮细胞未能形成毛细血管样管腔。因此,可以得出结论,VE-他汀/Egfl7可能调节内皮细胞的黏附,从而在恶性胶质瘤血管生成过程中内皮诱导的管腔形成中发挥重要作用。

相似文献

1
VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
Int J Clin Exp Pathol. 2014 Feb 15;7(3):1077-84. eCollection 2014.
2
VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network.
Int J Clin Exp Pathol. 2014 Feb 15;7(3):1022-31. eCollection 2014.
3
In-vitro inhibitory effect of EGFL7-RNAi on endothelial angiogenesis in glioma.
Int J Clin Exp Pathol. 2015 Oct 1;8(10):12234-42. eCollection 2015.
4
EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma.
Cancer Lett. 2017 Jan 1;384:9-18. doi: 10.1016/j.canlet.2016.10.009. Epub 2016 Oct 8.
6
VE-statin/egfl7 regulates vascular elastogenesis by interacting with lysyl oxidases.
EMBO J. 2008 Jun 18;27(12):1658-70. doi: 10.1038/emboj.2008.103. Epub 2008 May 22.
7
Expression and clinical significance of EGFL7 in malignant glioma.
J Cancer Res Clin Oncol. 2010 Nov;136(11):1737-43. doi: 10.1007/s00432-010-0832-9. Epub 2010 Mar 6.
9
microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.
Biomed Pharmacother. 2019 Aug;116:109007. doi: 10.1016/j.biopha.2019.109007. Epub 2019 Jun 3.
10
Endothelial Cell Activation Is Regulated by Epidermal Growth Factor-like Domain 7 (Egfl7) during Inflammation.
J Biol Chem. 2016 Nov 11;291(46):24017-24028. doi: 10.1074/jbc.M116.731331. Epub 2016 Sep 20.

引用本文的文献

3
KSHV LANA upregulates the expression of epidermal growth factor like domain 7 to promote angiogenesis.
Oncotarget. 2017 Dec 19;9(1):1210-1228. doi: 10.18632/oncotarget.23456. eCollection 2018 Jan 2.
4
Effect and Mechanism of Downregulation in Human Osteosarcoma Cells on the Biological Function of Co-cultured HUVEC.
Balkan Med J. 2018 Mar 15;35(2):155-162. doi: 10.4274/balkanmedj.2017.0045. Epub 2018 Jan 24.
5
Arginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathway.
Int J Mol Med. 2016 Mar;37(3):734-42. doi: 10.3892/ijmm.2016.2473. Epub 2016 Jan 29.
6
Genetic compensation induced by deleterious mutations but not gene knockdowns.
Nature. 2015 Aug 13;524(7564):230-3. doi: 10.1038/nature14580. Epub 2015 Jul 13.
7
Notching on Cancer's Door: Notch Signaling in Brain Tumors.
Front Oncol. 2015 Jan 5;4:341. doi: 10.3389/fonc.2014.00341. eCollection 2014.

本文引用的文献

1
Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer.
Int J Oncol. 2013 Apr;42(4):1367-75. doi: 10.3892/ijo.2013.1820. Epub 2013 Feb 8.
2
EGFL7 ligates αvβ3 integrin to enhance vessel formation.
Blood. 2013 Apr 11;121(15):3041-50. doi: 10.1182/blood-2011-11-394882. Epub 2013 Feb 5.
3
EGFL7: a unique angiogenic signaling factor in vascular development and disease.
Blood. 2012 Feb 9;119(6):1345-52. doi: 10.1182/blood-2011-10-322446. Epub 2011 Dec 7.
4
Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation.
Cancer Res. 2011 Dec 1;71(23):7176-86. doi: 10.1158/0008-5472.CAN-11-1301. Epub 2011 Oct 28.
5
Prognostic role of epidermal growth factor-like domain 7 protein expression in laryngeal squamous cell carcinoma.
J Laryngol Otol. 2011 Nov;125(11):1152-7. doi: 10.1017/S0022215111002441. Epub 2011 Sep 7.
6
Expression and clinical significance of EGFL7 in malignant glioma.
J Cancer Res Clin Oncol. 2010 Nov;136(11):1737-43. doi: 10.1007/s00432-010-0832-9. Epub 2010 Mar 6.
7
Slowdown promotes muscle integrity by modulating integrin-mediated adhesion at the myotendinous junction.
Development. 2010 Mar;137(5):785-94. doi: 10.1242/dev.043703. Epub 2010 Jan 28.
9
The role of Egfl7 in vascular morphogenesis.
Novartis Found Symp. 2007;283:18-28; discussion 28-36, 238-41. doi: 10.1002/9780470319413.ch3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验